Pricing AgreementPricing Agreement • November 15th, 2018 • Barclays PLC • Commercial banks, nec • New York
Contract Type FiledNovember 15th, 2018 Company Industry JurisdictionBarclays PLC (the “Company”) proposes to issue $1,750,000,000 aggregate principal amount of 4.610% Fixed-to-Floating Rate Senior Notes due 2023 (the “Fixed-to-Floating Rate Notes”) and $750,000,000 aggregate principal amount of Floating Rate Senior Notes due 2023 (the “Floating Rate Notes” and, together with the Fixed-to-Floating Rate Notes, the “Notes”). Each of the Underwriters hereby undertakes to purchase at the subscription price set forth in Schedule II hereto, the amount of Notes set forth opposite the name of such Underwriter in Schedules I-A and/or I-B hereto, such payment to be made at the Time of Delivery set forth in Schedule II hereto. The obligations of the Underwriters hereunder are several but not joint.
BARCLAYS PLC, Issuer, THE BANK OF NEW YORK MELLON, LONDON BRANCH, as Trustee and THE BANK OF NEW YORK MELLON SA/NV, LUXEMBOURG BRANCH as Senior Debt Security Registrar THIRD SUPPLEMENTAL INDENTURE Dated as of November 15, 2018 To the Senior Debt...Third Supplemental Indenture • November 15th, 2018 • Barclays PLC • Commercial banks, nec • New York
Contract Type FiledNovember 15th, 2018 Company Industry JurisdictionTHIRD SUPPLEMENTAL INDENTURE, dated as of November 15, 2018 (the “Third Supplemental Indenture”), among BARCLAYS PLC, a public limited company registered in England and Wales (herein called the “Company”), having its registered office at 1 Churchill Place, London E14 5HP, United Kingdom, THE BANK OF NEW YORK MELLON, LONDON BRANCH, a New York banking corporation, as Trustee and Paying Agent (herein called the “Trustee”), having a Corporate Trust Office at One Canada Square, London E14 5AL, United Kingdom, and THE BANK OF NEW YORK MELLON SA/NV, LUXEMBOURG BRANCH, as Senior Debt Security Registrar, having an office at 2-4 Rue Eugene Ruppert, Vertigo Building – Polaris, Luxembourg, 2453, Luxembourg, to the SENIOR DEBT SECURITIES INDENTURE, dated as of January 17, 2018, between the Company and the Trustee (as heretofore amended and supplemented, the “Base Indenture” and, together with this Third Supplemental Indenture, the “Indenture”).